Ultra Purification
Natural health product licensed in Canada
- Other names
- Ultra Purifiant, Ultra Purifiant Renew, Ultra Purifiant Renouveau
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80105020
- Status
- Active licence
- Licence date
- 8 October 2020
- Revision date
- 18 July 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cnicus benedictus Source : Sommité | 18.27 mg | Not calculated |
| Allium sativum Source : Bulbe | 3.045 mg | Not calculated |
| Bentonite Source : Bentonite | 5 mg | Not calculated |
| Trifolium pratense Source : Fleur | 23.143 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Extrait de graine de Pamplemousse, Hypromellose, Eau purifiée, Caprylate de calcium, Stéarate de magnésium, Caprylate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 5 Capsule | 2 |
Uses authorised in Canada
Psyllium is used in Herbal Medicine as a bulk-forming laxative, to promote bowel movements by increasing bulk volume and water content and to provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause gastrointestinal discomfort, such as upset stomach. Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. May cause temporary gas and/or bloating.
Source
Official Health Canada record, licence 80105020
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging